Effect of canagliflozin on urinary albumin excretion in type 2 diabetic patients with microalbuminuria (pilot study)
Phase of Trial: Phase II
Latest Information Update: 03 Jan 2018
At a glance
- Drugs Canagliflozin (Primary)
- Indications Diabetic nephropathies; Proteinuria
- Focus Therapeutic Use
- 27 Dec 2017 Status changed from recruiting to completed.
- 13 Oct 2016 Status changed from not yet recruiting to recruiting.
- 23 Sep 2016 New trial record